Market Overview

Mylan's CEO Showed 'Very Little Empathy,' Bill George Says

Share:
Mylan's CEO Showed 'Very Little Empathy,' Bill George Says

Bill George, a Harvard Business School senior fellow and ex-chairman of Medtronic PLC (NYSE: MDT) has some harsh words for Mylan NV (NASDAQ: MYL)'s CEO Heather Bresch.

Speaking as a guest on CNBC's "Squawk On The Street" on Wednesday, George said that Bresch could be in for a "rough time" as she is set to defend the company's policy of boosting the price of its life saving EpiPen in front of the U.S. Congress.

George even went on to say that Bresch "deserves it," especially after saying outrageous comments that "no one believes," including a claim Mylan doesn't make much money from the sale of its EpiPen.

Related Link: Mylan Investors Should Be Asking Where (And Who) Robert Coury Is

George continued that Bresch has tried to "obfuscate the issue by blaming the insurance companies and blaming everyone else."

"You don't take advantage of the consumer with rapid price increases like they have because you are going to get pushed back," he argued.

At the very least, George suggested Mylan roll back the price of its EpiPen to last year's level. He added that Bresch is even "harming people" and an apology is needed.

He also pointed out that executives at Mylan as a whole enjoy the second highest level of pay within the entire industry, which should be concerning since the company has "never invented a drug."

"I don't see how you can justify this," he added. "I think she has to apologize and get out front of the issue instead of being on the defensive and try to blame everyone else."

Bottom line, Bresch needs to change her tone as she has shown "very little empathy for the consumer."

Full ratings data available on Benzinga Pro.

Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!

Posted-In: Analyst Color Biotech News Health Care Previews Management Events Media Best of Benzinga

 

Related Articles (MYL + MDT)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
VREXNorthland SecuritiesInitiates Coverage On42.0
PFSWCraig-HallumDowngrades0.0
EAMorgan StanleyMaintains88.0
ELMorgan StanleyMaintains178.0
SPLKMorgan StanleyMaintains140.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Trader Essentials
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Goldman Reinstates Coverage Of Banco Bradesco Following Acquisition Of HSBC Brazil

Technical Alert: Netflix Lower On Domestic Subscriber Concerns